audit findings – Pharma GMP

25 Common Documentation Errors Seen During Batch Record Review

digi — Wed, 26 Nov 2025 01:30:04 +0000

25 Common Documentation Errors Seen During Batch Record Review Comprehensive Guide to 25 Common Documentation Errors During Batch Documentation Review Before QA Release In pharmaceutical manufacturing, batch documentation review before QA release is a critical quality assurance step to ensure product safety, efficacy, and regulatory compliance. Effective review prevents inadvertent release of non-conforming batches and...

Audit Findings Related to Inadequate Segregation of Strengths

digi — Wed, 26 Nov 2025 01:12:04 +0000

Audit Findings Related to Inadequate Segregation of Strengths in Pharmaceutical GMP Addressing Audit Findings on Inadequate Segregation of Different Strength Products GMP Ensuring the segregation of different strength products GMP is a fundamental requirement under pharmaceutical Good Manufacturing Practice regulations worldwide. Failures in this area frequently result in audit findings or regulatory warning letters, which...

Inspection Observations Related to Poor Raw Material Receipt Controls

digi — Tue, 25 Nov 2025 05:09:04 +0000

Inspection Observations Related to Poor Raw Material Receipt Controls Comprehensive Step-by-Step Guide to Strengthening Raw Material Receipt and Quarantine Procedures Raw materials are the foundation of pharmaceutical manufacturing. Ensuring their proper receipt, verification, and quarantine is essential to maintain product quality, patient safety, and regulatory compliance. However, inspection reports from authorities such as the FDA,...

Audit Findings Linked to Poor Control of Cleaning Tools

digi — Tue, 25 Nov 2025 01:42:42 +0000

Audit Findings Linked to Poor Control of Cleaning Tools Step-by-Step Guide to Improving Control of Cleaning Tools and Accessories in GMP Areas Effective control of cleaning tools and accessories in GMP areas is a critical component of pharmaceutical manufacturing to prevent cross contamination, ensure product quality, and maintain regulatory compliance. Audit findings frequently highlight deficiencies...

Audit Findings Linked to Poor Use of Cleaning Checklists

digi — Tue, 25 Nov 2025 00:03:42 +0000

Audit Findings Linked to Poor Use of Cleaning Checklists Improving Compliance Through Effective GMP Cleaning Checklists for Production Equipment Within pharmaceutical manufacturing environments governed by stringent regulatory frameworks such as FDA 21 CFR Parts 210 and 211, EU GMP Volume 4 including Annex 15, and PIC/S GMP guidelines, the cleaning of production equipment is an...

Typical Line Clearance Deficiencies Found During GMP Audits

digi — Mon, 24 Nov 2025 17:48:42 +0000

Typical Line Clearance Deficiencies Found During GMP Audits Comprehensive Step-by-Step Guide on Line Clearance Procedure Before Batch Start: Identifying & Correcting Common Deficiencies The line clearance procedure before batch start is a critical control point in Good Manufacturing Practice (GMP) manufacturing environments across the pharmaceutical industry. Accurate and thorough line clearance ensures that no cross-contamination,...

Common GMP Manufacturing Process Control Failures and How to Prevent Them

digi — Mon, 24 Nov 2025 17:06:42 +0000

Common GMP Manufacturing Process Control Failures and How to Prevent Them Step-by-Step Guide to Preventing Common GMP Manufacturing Process Control Failures Ensuring robust GMP manufacturing process control is fundamental to pharmaceutical product quality, patient safety, and regulatory compliance. However, despite well-established principles codified by regulatory frameworks such as 21 CFR Parts 210/211 (FDA), EU GMP...